Article
Translating gastric cancer genomics into targeted therapies
20 Feb 2016
Abstract excerpt
Gastric cancer is a common disease with limited treatment options and a poor prognosis. Many gastric cancers harbour potentially actionable targets, including over-expression and mutations in tyrosine kinase pathways. Agents have been developed against these targets with varying success- in particular, the use of trastuzumab in HER2-overexpressing gastric cancers has resulted in overall survival benefits. Gastric...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
